|
|
Volumn 69, Issue 5, 2010, Pages 425-426
|
|
New drug mechanisms
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR;
BRADYKININ;
BRADYKININ B2 RECEPTOR;
COMPLEMENT COMPONENT C1S INHIBITOR;
ICATIBANT;
KALLIKREIN;
KININ;
DRUG DERIVATIVE;
ANGIONEUROTIC EDEMA;
BLOOD VESSEL PERMEABILITY;
CLINICAL PRACTICE;
CORONARY ARTERY BLOOD FLOW;
DIZZINESS;
DRUG MARKETING;
DRUG MECHANISM;
ERYTHEMA;
EUROPE;
GASTROINTESTINAL SYMPTOM;
HEART FUNCTION;
HUMAN;
INJECTION SITE SWELLING;
INTERSTITIUM;
LARYNX EDEMA;
MEDICINE;
METABOLISM;
NOCICEPTIVE RECEPTOR;
NOSE CONGESTION;
PRIORITY JOURNAL;
PUBLICATION;
RASH;
SHORT SURVEY;
SIDE EFFECT;
SIGNAL TRANSDUCTION;
SKIN REDNESS;
SYMPTOM;
VASODILATATION;
ACUTE DISEASE;
ARTICLE;
DRUG ANTAGONISM;
ACUTE DISEASE;
ANGIOEDEMAS, HEREDITARY;
BRADYKININ;
COMPLEMENT C1 INHIBITOR PROTEIN;
HUMANS;
RECEPTOR, BRADYKININ B2;
|
|
EID: 77950661608
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.2010.03642.x Document Type: Short Survey |
|
Times cited : (16)
|
|
References (2)
|
